Article
Risk factors associated with inhibitor development in Chinese patients with haemophilia B.
Haemophilia : the official journal of the World Federation of Hemophilia - 1 Jul 2015
Zhou J, Ding Q, Chen Z, Yang H, Lin L, Wang H, Wang X, Wu R
Abstract excerpt
INTRODUCTION: Inhibitor development is a severe complication of factor IX substitution treatment for haemophilia B (HB). Current research examined the association between inhibitor development and F9 genotypes and polymorphisms in immune response genes in Chinese HB patients. MATERIALS AND METHODS: 11 inhibitor-positive HB patients and 41 inhibitor-negative HB patients were enrolled. Direct sequencing, copy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
